Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
Business Facilities magazine has named North Carolina its 'State of the Year' for business climate and economic development, the state's third such win in six years, following a surge of multi-billion dollar investments from tech and manufacturing giants.
A 65-year-old Thai tourist was killed by a bull elephant with a known history of aggression in Khao Yai National Park, marking the animal's third human fatality and prompting urgent discussions on wildlife management strategies.
AbbVie's stock presents a complex picture for investors, with recent mixed performance contrasting sharply with its robust multi-year returns. As shares trade below consensus targets, the market weighs near-term headwinds against the pharmaceutical giant's proven track record and pipeline potential.
A coalition of environmental groups is sounding the alarm over two massive Royal Caribbean developments in Cozumel and Mahahual, warning of severe ecological strain and social disruption, as legal challenges begin to mount.
The White House announces a major public-private initiative to stockpile rare earths and critical minerals, aiming to insulate U.S. defense and tech sectors from foreign supply shocks and geopolitical leverage.
Fresh financial data from QuidelOrtho reveals ongoing challenges, including constant currency revenue declines and pressured cash flow, forcing investors to weigh the stock's risk-reward profile as its momentum appears to fade.
Nvidia CEO Jensen Huang has publicly committed to a landmark investment in OpenAI, calling it potentially the company's largest ever, while forcefully refuting reports of hesitation. The move deepens the strategic ties between the AI chip giant and the leading AI research lab.
Life sciences and diagnostics firm Revvity (RVTY) closed 2025 with results surpassing internal targets, driven by robust diagnostics performance. While management provided initial 2026 guidance, it remains conservative, banking on market stabilization rather than a broad recovery.
As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.
A U.S.-sanctioned Russian cargo aircraft, linked to prior military support in Venezuela, landed at a Cuban military airfield. The arrival coincides with a declared U.S. national emergency over Cuba and fuels concerns over Moscow's strategic activities in America's backyard.
The so-called 'Super Bowl Indicator' correctly predicted a market rise after last year's NFC win, but a deeper look at the data reveals it's little more than a coin toss—and a cautionary tale about spurious correlations in finance.
Amazon will discontinue its Amazon One palm-scanning payment and entry technology at retail locations in 2026, marking a retreat from one of its most ambitious physical commerce experiments.
After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
A Barcelona hospital has completed a groundbreaking facial transplant, the first of its kind globally where the donor offered her face as part of an assisted dying process. The recipient, who lost facial function to a severe infection, is now recovering well.
AIGH Capital Management has liquidated its entire position in semiconductor firm MaxLinear, a move that coincides with the chipmaker's recent strong quarterly earnings report, raising questions about the fund's strategy.
As the 2026 Winter Olympics approach, the event is set to be the final one governed by a fragmented system of regulations for transgender athletes' participation. With the IOC poised to introduce universal guidelines, the Games in Italy spotlight a global debate balancing inclusion, fairness, and the future of women's sport.
Senator James Lankford's annual oversight report details what he calls wasteful federal spending, including controversial NIH-funded projects on transgender-related animal testing and aborted fetal tissue research, reigniting debates on scientific priorities and fiscal responsibility.
As crypto prediction markets surge past $6B in weekly volume, a new phase of growth beckons. Driven by institutional interest, regulatory evolution, and AI integration, these platforms are poised to redefine speculative finance.
With one in twelve salaried employees having worked in multiple countries, Colgate-Palmolive is leveraging international assignments as a core strategy to build agile, globally-minded leadership.
